517P Real-world efficacy and safety of immune checkpoint inhibitors (ICI) in gastrointestinal tumors with mismatch repair deficiency or microsatellite instability (dMMR/MSI-H)Jun 26, 2024 | Comunicaciones a congresos, ESMO, Marta Covela Rúa
Rechallenge with Anti-EGFR Treatment in RAS/BRAF wt Metastatic Colorectal Cancer (mCRC) in Real Clinical Practice: Experience of the GITuD GroupMay 23, 2024 | Alberto Carral Maseda, Marta Covela Rúa, Publicaciones científicas
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)Abr 17, 2024 | Marta Covela Rúa, Publicaciones científicas
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?Mar 13, 2024 | Marta Covela Rúa, Publicaciones científicas
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastomaFeb 16, 2024 | Marta Covela Rúa, Publicaciones científicas
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastomaFeb 16, 2024 | Marta Covela Rúa, Publicaciones científicas
State of the scientific evidence and recommendations for the management of older patients with gastric cancerNov 11, 2023 | Marta Covela Rúa, Publicaciones científicas
